A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Phase 3
330
about 1.4 years
18–85
32 sites in AL, AR, AZ +14
About this study
Researchers are testing whether CYB003, an adjunctive treatment to psychological support, can help people with major depressive disorder. The trial will last for 514 days and involve approximately 330 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Psychological Support
- 2.Take CYB003
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Montgomery-Asberg Depression Scale (MADRS)
Secondary: The Beck Depression Inventory - Second Edition (BDI-II), The Generalized Anxiety Disorder 7-Item Scale (GAD-7), The Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF)
Psychiatry / Mental Health